诺华-话题@MedSci

#诺华#

235篇内容 | 5237人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1282753, encodeId=8e011282e533d, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=FDA批准诺华的Piqray用于治疗PIK3CA突变的晚期或转移性乳腺癌, objectType=article, longId=167492, objectId=4e2216e4929e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e2216e4929e, replyNumber=0, likeNumber=68, createdTime=2019-06-03, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e2216e4929e, moduleTitle=FDA批准诺华的Piqray用于治疗PIK3CA突变的晚期或转移性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e2216e4929e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282752, encodeId=39421282e523f, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华的吸入型联合疗法QMF149治疗哮喘III期试验达到实验终点, objectType=article, longId=167489, objectId=a85316e489c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a85316e489c3, replyNumber=0, likeNumber=80, createdTime=2019-06-03, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a85316e489c3, moduleTitle=诺华的吸入型联合疗法QMF149治疗哮喘III期试验达到实验终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a85316e489c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282751, encodeId=24031282e5111, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=晚期乳腺癌：诺华公司的PI3K抑制剂Piqray获FDA授权, objectType=article, longId=166798, objectId=fe2e166e985f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2e166e985f, replyNumber=0, likeNumber=70, createdTime=2019-05-27, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2e166e985f, moduleTitle=晚期乳腺癌：诺华公司的PI3K抑制剂Piqray获FDA授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2e166e985f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282750, encodeId=c8861282e5075, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=显著改善认知能力，诺华公布多发性硬化症新药全新数据分析, objectType=article, longId=166061, objectId=e9c816606197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9c816606197, replyNumber=0, likeNumber=74, createdTime=2019-05-16, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9c816606197, moduleTitle=显著改善认知能力，诺华公布多发性硬化症新药全新数据分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9c816606197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282749, encodeId=ee621282e4964, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=药物警戒：诺华公司在美国范围内自愿召回Promacta 12.5 mg口服悬浮剂, objectType=article, longId=165993, objectId=91ee16599363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91ee16599363, replyNumber=0, likeNumber=101, createdTime=2019-05-15, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91ee16599363, moduleTitle=药物警戒：诺华公司在美国范围内自愿召回Promacta 12.5 mg口服悬浮剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91ee16599363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282748, encodeId=b7741282e48d0, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华的脊髓性肌萎缩症基因治疗药物Zolgensma，临床试验中出现第二次死亡事件, objectType=article, longId=164833, objectId=2160164833a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2160164833a3, replyNumber=0, likeNumber=80, createdTime=2019-04-24, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2160164833a3, moduleTitle=诺华的脊髓性肌萎缩症基因治疗药物Zolgensma，临床试验中出现第二次死亡事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2160164833a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282747, encodeId=b0931282e47c9, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华的CDK4/6靶向性抑制剂Kisqali遭NICE拒绝，用于治疗晚期乳腺癌, objectType=article, longId=164062, objectId=b2ee164062f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2ee164062f7, replyNumber=0, likeNumber=60, createdTime=2019-04-12, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2ee164062f7, moduleTitle=诺华的CDK4/6靶向性抑制剂Kisqali遭NICE拒绝，用于治疗晚期乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2ee164062f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282746, encodeId=7d661282e460e, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市, objectType=article, longId=163639, objectId=30a2163639f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30a2163639f7, replyNumber=0, likeNumber=78, createdTime=2019-04-06, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30a2163639f7, moduleTitle=诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30a2163639f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282745, encodeId=5a5d1282e4502, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华15.75亿美元收购IFM Tre，拓展免疫药物管线, objectType=article, longId=163498, objectId=de6716349807, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de6716349807, replyNumber=0, likeNumber=63, createdTime=2019-04-04, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de6716349807, moduleTitle=诺华15.75亿美元收购IFM Tre，拓展免疫药物管线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de6716349807)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282744, encodeId=50461282e4455, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华将以16亿美元收购IFM Tre以强化其抗炎药物组合研发管线, objectType=article, longId=163430, objectId=0db916343049, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0db916343049, replyNumber=0, likeNumber=85, createdTime=2019-04-03, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0db916343049, moduleTitle=诺华将以16亿美元收购IFM Tre以强化其抗炎药物组合研发管线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0db916343049)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282743, encodeId=1d6c1282e43df, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=始于中国，布局全球：诺华制药与腾讯深化合作，支持慢性病管理, objectType=article, longId=162784, objectId=6c16162e8471, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c16162e8471, replyNumber=0, likeNumber=67, createdTime=2019-03-24, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c16162e8471, moduleTitle=始于中国，布局全球：诺华制药与腾讯深化合作，支持慢性病管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c16162e8471)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282742, encodeId=47661282e42cd, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=药品带量采购后续：诺华、正大天晴、石药集团等企业主动降价, objectType=article, longId=161827, objectId=2b5416182e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b5416182e03, replyNumber=0, likeNumber=70, createdTime=2019-03-08, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b5416182e03, moduleTitle=药品带量采购后续：诺华、正大天晴、石药集团等企业主动降价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b5416182e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282741, encodeId=2b0a1282e41a9, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华司库奇尤单抗（俗称“苏金单抗”）中国数据首度发布, objectType=article, longId=161713, objectId=446d161e139c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=446d161e139c, replyNumber=0, likeNumber=77, createdTime=2019-03-07, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=446d161e139c, moduleTitle=诺华司库奇尤单抗（俗称“苏金单抗”）中国数据首度发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=446d161e139c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282740, encodeId=3fc21282e4096, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华的呼吸道合胞病毒疫苗ResVax在III期临床研究中失败, objectType=article, longId=161507, objectId=c9f516150e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9f516150e26, replyNumber=0, likeNumber=72, createdTime=2019-03-03, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9f516150e26, moduleTitle=诺华的呼吸道合胞病毒疫苗ResVax在III期临床研究中失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9f516150e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282739, encodeId=96101282e39a0, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华和黑石生命科学公司合作开发心血管预防性新药MAA868, objectType=article, longId=161506, objectId=131e1615063b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=131e1615063b, replyNumber=0, likeNumber=68, createdTime=2019-03-03, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=131e1615063b, moduleTitle=诺华和黑石生命科学公司合作开发心血管预防性新药MAA868, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=131e1615063b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282738, encodeId=25f81282e3840, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华公司获得授权Akcea的新型心血管治疗药物, objectType=article, longId=161113, objectId=0e0d16111313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e0d16111313, replyNumber=0, likeNumber=53, createdTime=2019-02-27, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e0d16111313, moduleTitle=诺华公司获得授权Akcea的新型心血管治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e0d16111313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282737, encodeId=b1211282e3730, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=日本即将批准诺华CAR-T药物Kymriah上市，可能纳入日本国民健康保险系统, objectType=article, longId=160817, objectId=c87c16081ebb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c87c16081ebb, replyNumber=0, likeNumber=68, createdTime=2019-02-24, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c87c16081ebb, moduleTitle=日本即将批准诺华CAR-T药物Kymriah上市，可能纳入日本国民健康保险系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c87c16081ebb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282736, encodeId=33241282e36d0, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华敦促英国政府在脱欧时"尽量减少对药物供应的干扰", objectType=article, longId=159144, objectId=1260159144d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1260159144d0, replyNumber=0, likeNumber=71, createdTime=2019-01-30, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1260159144d0, moduleTitle=诺华敦促英国政府在脱欧时"尽量减少对药物供应的干扰", moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1260159144d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282735, encodeId=d3b41282e3591, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华与牛津大学合作利用人工智能进行药物开发, objectType=article, longId=158986, objectId=661e15898655, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=661e15898655, replyNumber=0, likeNumber=71, createdTime=2019-01-28, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=661e15898655, moduleTitle=诺华与牛津大学合作利用人工智能进行药物开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=661e15898655)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282734, encodeId=83161282e3416, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华与京东医药深化合作探索糖尿病健康管理新模式, objectType=article, longId=154278, objectId=36381542e86b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36381542e86b, replyNumber=0, likeNumber=67, createdTime=2018-11-25, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36381542e86b, moduleTitle=诺华与京东医药深化合作探索糖尿病健康管理新模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36381542e86b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

诺华

2020-05-29发表于威斯康星

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

FDA批准诺华的Piqray用于治疗PIK3CA突变的晚期或转移性乳腺癌

2019-06-03

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华的吸入型联合疗法QMF149治疗哮喘III期试验达到实验终点

2019-06-03

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

晚期乳腺癌：诺华公司的PI3K抑制剂Piqray获FDA授权

2019-05-27

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

显著改善认知能力，诺华公布多发性硬化症新药全新数据分析

2019-05-16

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

药物警戒：诺华公司在美国范围内自愿召回Promacta 12.5 mg口服悬浮剂

2019-05-15

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华的脊髓性肌萎缩症基因治疗药物Zolgensma，临床试验中出现第二次死亡事件

2019-04-24

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华的CDK4/6靶向性抑制剂Kisqali遭NICE拒绝，用于治疗晚期乳腺癌

2019-04-12

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市

2019-04-06

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华15.75亿美元收购IFM Tre，拓展免疫药物管线

2019-04-04

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华将以16亿美元收购IFM Tre以强化其抗炎药物组合研发管线

2019-04-03

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

始于中国，布局全球：诺华制药与腾讯深化合作，支持慢性病管理

2019-03-24

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

药品带量采购后续：诺华、正大天晴、石药集团等企业主动降价

2019-03-08

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华司库奇尤单抗（俗称“苏金单抗”）中国数据首度发布

2019-03-07

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华的呼吸道合胞病毒疫苗ResVax在III期临床研究中失败

2019-03-03

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华和黑石生命科学公司合作开发心血管预防性新药MAA868

2019-03-03

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华公司获得授权Akcea的新型心血管治疗药物

2019-02-27

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

日本即将批准诺华CAR-T药物Kymriah上市，可能纳入日本国民健康保险系统

2019-02-24

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华敦促英国政府在脱欧时"尽量减少对药物供应的干扰"

2019-01-30

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华与牛津大学合作利用人工智能进行药物开发

2019-01-28

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华与京东医药深化合作探索糖尿病健康管理新模式

2018-11-25

科室
- - 订阅+
  - 更多科室
工具
服务